Treace Medical signals 2026 revenue target of $200M–$212M while expanding comprehensive bunion solutions

Q4 2025 earnings call recap: revenue, margins, 2026 guidance, bunion portfolio growth, and cash burn cuts—read key takeaways.

Caris Life Sciences targets 23–26% revenue growth and $1B milestone in 2026 while expanding early detection investments

Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...